ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
Done
Inviting an author to review:
The Life Cycle Assessment for Polylactic Acid (PLA) to Make It a Low-Carbon Material
Find an author and click ‘
Invite to review selected article
’ near their name.
Search for authors
Search for similar articles
Invite by email
1
views
0
references
Top references
cited by
11
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,731
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Gemcitabine: current status of phase I and II trials.
Author(s):
Keith S. Kaye
Publication date:
1994-07-31
Journal:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Keywords:
Antimetabolites, Antineoplastic
,
therapeutic use
,
Carcinoma, Non-Small-Cell Lung
,
drug therapy
,
Clinical Trials, Phase I as Topic
,
Clinical Trials, Phase II as Topic
,
Deoxycytidine
,
analogs & derivatives
,
Drug Administration Schedule
,
Humans
,
Lung Neoplasms
,
Research
Read this article at
ScienceOpen
PubMed
Review
Review article
Invite someone to review
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
EPA CompTox Chemicals Dashboard
Author and article information
Journal
PubMed ID::
8040662
ScienceOpen disciplines:
Chemistry
Keywords:
Antimetabolites, Antineoplastic
,
therapeutic use
,
Carcinoma, Non-Small-Cell Lung
,
drug therapy
,
Clinical Trials, Phase I as Topic
,
Clinical Trials, Phase II as Topic
,
Deoxycytidine
,
analogs & derivatives
,
Drug Administration Schedule
,
Humans
,
Lung Neoplasms
,
Research
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Antimetabolites, Antineoplastic
,
therapeutic use
,
Carcinoma, Non-Small-Cell Lung
,
drug therapy
,
Clinical Trials, Phase I as Topic
,
Clinical Trials, Phase II as Topic
,
Deoxycytidine
,
analogs & derivatives
,
Drug Administration Schedule
,
Humans
,
Lung Neoplasms
,
Research
Comments
Comment on this article
Sign in to comment
Similar content
1,731
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.
Authors:
Helmut Oettle
,
Stefan Post
,
Peter Neuhaus
…
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study
Authors:
Philip Philip
,
Jill Lacy
,
Fabienne Portales
…
A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407).
Authors:
Masato Ozaka
,
Kohei Nakachi
,
Satoshi Kobayashi
…
See all similar
Cited by
10
Patient-derived tumor-like cell clusters for drug testing in cancer therapy
Authors:
Shenyi Yin
,
Ruibin Xi
,
Aiwen Wu
…
Cell cycle perturbation induced by gemcitabine in human tumor cells in cell culture, xenografts and bladder cancer patients: implications for clinical trial designs combining gemcitabine with a Chk1 inhibitor
Authors:
Ryan Montano
,
Nadeem Khan
,
Huagang Hou
…
Preclinical relevance of dosing time for the therapeutic index of gemcitabine–cisplatin
Authors:
X. M. Li
,
K Tanaka
,
J. Sun
…
See all cited by